Media ReleasesSomnomed Limited

View All Somnomed Limited News


SomnoMed Announces Change in Leadership

19th November 2018, SomnoMed (ASX:SOM) announced today that it had reached agreement with its Chief Executive Mr Derek Smith to step down from his position effective 16th November 2018. Mr Smith served as CEO of SomnoMed since 1st September 2016. The Board thanked Mr Smith for his work during his tenure, especially in upgrading the company’s capabilities in the Quality & Regulatory Assurance, the Global Production and the Product Development departments.

The Board of SomnoMed has appointed Mr Neil Verdal-Austin as the new Chief Executive of SomnoMed effective 19th November 2018. Mr Verdal-Austin has served as Chief Financial Officer of SomnoMed Limited since October 2008. During this time he also took direct management responsibility for SomnoMed’s APAC region, managing the Company’s businesses in Australia, New Zealand, Singapore and South Korea successfully over a period of four years to the end of June this year.


For further information please download PDF attached:
Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.